Business
Covalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference
Covalon to Introduce New Infection Prevention Products at the Annual Association of Pedia...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n \n \n \n Covalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Ensuring that health professionals caring for the youngest patients have access to advanced wound care and infection prevention solutions\n \n \n \n \n Visit Covalon at booth 307 at the 46th Annual APHON Conference & Exhibit in\n \n West Palm Beach\n \n on\n \n September 15\n \n – 17, 2022\n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n Sept. 13, 2022\n \n \n /CNW/ - Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, is pleased to announce its participation in the 46th Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference & Exhibit at the\n \n Palm Beach County\n \n Convention Center in\n \n West Palm Beach, Florida\n \n on\n \n September 15\n \n – 17, 2022.  Visit Covalon at booth 307 to learn how our infection prevention and advanced wound care products are making a difference in the lives of our youngest patients.\n \n \n \n \n \n \n \n \n \n With more than 25 leading children's hospitals currently using or evaluating Covalon's VALGuard product, the world's only FDA-approved vascular access line guard, the need to find a solution to help protect line-to-line connections to reduce central line associated bloodstream infections (\"CLABSIs\") has never been greater.  Bloodstream infections are up 65% in intensive care units, and there is an urgent need to adopt new compassionate care technologies in the fight to protect patients.\n \n \n \"Effective infection prevention strategies require the best products targeted at the contributors to the risk of infection,\" started\n \n Brian Pedlar\n \n , CEO of Covalon.  \"With studies indicating up to 71% of catheter-related infections being linked to catheter hub contamination – Covalon's VALGuard product...